American Well (AMWL) Stock Price, News & Analysis

Company Overview

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Key Stats

• Today's Range: $7.25 to $7.56
• 50-Day Range: $6.23 to $8.20
• 52-Week Range: $5.00 to $12.95
• Volume: 32,635 shs
• Average Volume: 89,230 shs
• Market Capitalization: $116.14 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $10.00
• Consensus Rating: Hold

American Well Stock Analysis - MarketRank™

American Well scored higher than 57% of companies evaluated by MarketBeat, and ranked 437th out of 915 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.1 / 5
• Analyst Rating: Hold

Consensus Rating

American Well has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on 1 buy rating, 5 hold ratings, and no sell ratings.

Amount of Analyst Coverage

American Well has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for American Well are expected to grow in the coming year, from ($9.34) to ($6.09) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of American Well is -0.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of American Well is -0.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

American Well has a P/B Ratio of 0.37. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.43% of the float of American Well has been sold short.

Short Interest Ratio / Days to Cover

American Well has a short interest ratio ("days to cover") of 4.2.

Change versus previous month

Short interest in American Well has recently decreased by 16.78%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

American Well does not currently pay a dividend.

Dividend Growth

American Well does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

2.43% of the float of American Well has been sold short.

Short Interest Ratio / Days to Cover

American Well has a short interest ratio ("days to cover") of 4.2.

Change versus previous month

Short interest in American Well has recently decreased by 16.78%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, American Well insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $43,217.00 in company stock.

Percentage Held by Insiders

11.82% of the stock of American Well is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

56.05% of the stock of American Well is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

AMWL Stock Analysis - Frequently Asked Questions

How have AMWL shares performed this year?

American Well's stock was trading at $7.25 at the start of the year. Since then, AMWL shares have increased by 2.6% and is now trading at $7.44.
View the best growth stocks for 2025 here.

How were American Well's earnings last quarter?

American Well Co. (NYSE:AMWL) announced its quarterly earnings results on Thursday, May, 1st. The company reported ($1.73) EPS for the quarter, beating analysts' consensus estimates of ($3.09) by $1.36. The firm earned $66.83 million during the quarter, compared to the consensus estimate of $60.15 million. American Well had a negative trailing twelve-month return on equity of 56.73% and a negative net margin of 81.83%.
Read the conference call transcript.

When did American Well's stock split?

American Well shares reverse split on Thursday, July 11th 2024. The 1-20 reverse split was announced on Thursday, July 11th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, July 11th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

When did American Well IPO?

American Well (AMWL) raised $525 million in an IPO on Thursday, September 17th 2020. The company issued 35,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, Goldman Sachs, PIper Sandler, UBS Investment Bank, Credit Suisse, Cowen and Berenberg served as the underwriters for the IPO.

Who are American Well's major shareholders?

American Well's top institutional investors include Acadian Asset Management LLC (1.21%), Rock Point Advisors LLC (0.90%), Goldman Sachs Group Inc. (0.41%) and Jane Street Group LLC (0.41%). Insiders that own company stock include Kathy Johnson Weiler, Phyllis Gotlib, Kurt Knight, Roy Schoenberg, Vukasin Paunovich, Robert Shepardson, Ido Schoenberg, Bradford Gay, Serkan Kutan, Deborah C Jackson, Paul Francis Mcneice, Stephen J Schlegel and Peter L Slavin.
View institutional ownership trends.

How do I buy shares of American Well?

Shares of AMWL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of American Well own?

Based on aggregate information from My MarketBeat watchlists, some other companies that American Well investors own include Meta Platforms (META), NVIDIA (NVDA), Teladoc Health (TDOC), Tesla (TSLA), PayPal (PYPL) and Zoom Video Communications (ZM).

Company Calendar

• Last Earnings: 5/01/2025
• Today: 5/22/2025
• Next Earnings (Estimated): 7/30/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Business services, not elsewhere classified
• Sub-Industry: Business Services
• Current Symbol: NYSE:AMWL
• CIK: 1393584
• Web: amwell.com
• Phone: 617-204-3500
• Fax: N/A
• Employees: 1,040
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $10.00
• High Stock Price Target: $15.00
• Low Stock Price Target: $7.50
• Potential Upside/Downside: +34.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.17
• Research Coverage: 6 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($10.19)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-208,140,000.00
• Net Margins: -81.83%
• Pretax Margin: -81.29%
• Return on Equity: -56.73%
• Return on Assets: -42.15%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.85
• Quick Ratio: 2.82

Sales & Book Value

• Annual Sales: $261.68 million
• Price / Sales: 0.44
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $20.31 per share
• Price / Book: 0.37

Miscellaneous

• Outstanding Shares: 15,610,000
• Free Float: 13,612,000
• Market Cap: $116.14 million
• Optionable: Optionable
• Beta: 1.22